Literature DB >> 26361025

[Comparison of two methods to assess causality of adverse drug reactions].

Mónica Kyonen, Isabel Folatre, Ximena Lagos, Silvia Vargas.   

Abstract

BACKGROUND: Assessment of causality is an essential part of pharmacological surveillance. AIM: To compare the causality assessment of suspected adverse drug reactions (ADRs) using algorithms proposed by Karch-Lasagna (K & L) and the World Health Organization (WHO).
MATERIAL AND METHODS: All spontaneous reports of suspected ADRs in a pediatric ward of a regional hospital were included. Causality was categorized as definitive, probable, possible, conditional or unlikely. The agreement between K & L and WHO algorithms was assessed using binomial test proportions and kappa coefficients.
RESULTS: One hundred thirty reports of ADRs in 126 patients aged 2 to 11 years were analyzed. The suspected medications were antineoplastic drugs in 59% of cases and antimicrobials in 23%. The most common affected system was the skin and appendages in 35%. Using K & L algorithm, causality was categorized as definitive in 10% of cases, probable in 28.5%, possible in 35.4%, conditional in 23.1% and unlikely in 3.0%. Using WHO algorithm, the figures were 2.3, 34.6, 59.2, 2.3 and 1.5%, respectively. The degree of agreement between K & L and WHO algorithms was 32.3% (kappa = 0.004).
CONCLUSIONS: K & L attributed a higher level of ADR causality than WHO algorithm.

Entities:  

Mesh:

Year:  2015        PMID: 26361025     DOI: 10.4067/S0034-98872015000700009

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  2 in total

1.  Comparison of different methods for causality assessment of adverse drug reactions.

Authors:  Sapan Kumar Behera; Saibal Das; Alphienes Stanley Xavier; Srinivas Velupula; Selvarajan Sandhiya
Journal:  Int J Clin Pharm       Date:  2018-07-26

2.  Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.

Authors:  Inés Jiménez-Lozano; José Manuel Caro-Teller; Nuria Fernández-Hidalgo; Marta Miarons; Marie Antoinette Frick; Emma Batllori Badia; Berta Serrano; Carlos Javier Parramon-Teixidó; Fátima Camba-Longueira; Maria Teresa Moral-Pumarega; Rafael San Juan-Garrido; Maria Josep Cabañas Poy; Anna Suy; Maria Queralt Gorgas Torner
Journal:  J Clin Pharm Ther       Date:  2021-02-26       Impact factor: 2.145

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.